Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CATX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Markus Puhlmann Chief Medical Officer | CATX Perspective Therapeutics, Inc. | Buy | 35,000 | $0.8447 | $29.6K Buy | Form 4 ↗ |
| Nov 11, 2026 | Markus Puhlmann Chief Medical Officer | CATX Perspective Therapeutics, Inc. | Buy | 6,000 | $0.83 | $4,980 Buy | Form 4 ↗ |
| Nov 11, 2026 | Johan M. Spoor Chief Executive Officer, Director | CATX Perspective Therapeutics, Inc. | Buy | 47,000 | $0.8073 | $37.9K Buy | Form 4 ↗ |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 167,149 | $3.15 | $526.5K Sale | Form 4 ↗ |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 80,783 | $3.11 | $251.2K Sale | Form 4 ↗ |
| Sep 2, 2026 | Lantheus Holdings, Inc. 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 42,129 | $3.11 | $131.0K Sale | Form 4 ↗ |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 35,769 | $3.12 | $111.6K Sale | Form 4 ↗ |
| Sep 1, 2026 | Lantheus Holdings, Inc. 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 35,769 | $3.12 | $111.6K Sale | Form 4 ↗ |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 78,145 | $3.14 | $245.4K Sale | Form 4 ↗ |
| Aug 31, 2026 | Lantheus Holdings, Inc. 10% owner | CATX Perspective Therapeutics, Inc. | Sale | 78,145 | $3.14 | $245.4K Sale | Form 4 ↗ |
| Nov 13, 2025 | Jonathan Robert Hunt Chief Accounting Officer | CATX Perspective Therapeutics, Inc. | Buy | 11,000 | $2.03 | $22.3K Buy | Form 4 ↗ |
| Nov 12, 2025 | Robert F. Williamson III Director | CATX Perspective Therapeutics, Inc. | Buy | 9,498 | $2.10 | $19.9K Buy | Form 4 ↗ |
| Mar 31, 2025 | Robert F. Williamson III Director | CATX Perspective Therapeutics, Inc. | Buy | 38,145 | $2.14 | $81.6K Buy | Form 4 ↗ |
| Mar 31, 2025 | Lori A. Woods Director | CATX Perspective Therapeutics, Inc. | Buy | 23,475 | $2.13 | $50.0K Buy | Form 4 ↗ |
| Mar 28, 2025 | Johan M. Spoor Chief Executive Officer, Director | CATX Perspective Therapeutics, Inc. | Buy | 4,650 | $2.21 | $10.3K Buy | Form 4 ↗ |
| Mar 28, 2025 | Johan M. Spoor Chief Executive Officer, Director | CATX Perspective Therapeutics, Inc. | Buy | 22,026 | $2.24 | $49.3K Buy | Form 4 ↗ |
| Mar 28, 2025 | Robert F. Williamson III Director | CATX Perspective Therapeutics, Inc. | Buy | 22,192 | $2.27 | $50.4K Buy | Form 4 ↗ |
| Mar 28, 2025 | Juan Graham Chief Financial Officer | CATX Perspective Therapeutics, Inc. | Buy | 33,333 | $2.25 | $75.0K Buy | Form 4 ↗ |
| Dec 4, 2024 | Heidi Henson Director | CATX Perspective Therapeutics, Inc. | Buy | 25,975 | $3.85 | $100.0K Buy | Form 4 ↗ |
| Dec 4, 2024 | Johan M. Spoor CEO, Director | CATX Perspective Therapeutics, Inc. | Buy | 8,000 | $3.77 | $30.2K Buy | Form 4 ↗ |
| Nov 25, 2024 | Jonathan Robert Hunt Chief Financial Officer | CATX Perspective Therapeutics, Inc. | Buy | 10,000 | $3.88 | $38.8K Buy | Form 4 ↗ |
| Nov 25, 2024 | Jonathan Robert Hunt Chief Financial Officer | CATX Perspective Therapeutics, Inc. | Buy | 2,400 | $3.60 | $8,640 Buy | Form 4 ↗ |
| Nov 25, 2024 | Jonathan Robert Hunt Chief Financial Officer | CATX Perspective Therapeutics, Inc. | Buy | 29 | $3.94 | $114 Buy | Form 4 ↗ |
| Nov 25, 2024 | Jonathan Robert Hunt Chief Financial Officer | CATX Perspective Therapeutics, Inc. | Buy | 400 | $3.55 | $1,420 Buy | Form 4 ↗ |
24 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances